|
|
 |
|
Viewing report
|
|
|
|
U.S. Bio-Computing IT Market Bio-Computing & Pharmaceutical Companies, The Fusion of Computing and Drug Discovery: Technologies, Products, Vendors, Opportunities and Market Forecasts
Fuji-Keizai USA, Inc., Pages: 147
1. The Market for Bio-Computing + Pharmaceuticals1.1 Definition of Bio-Computing + Pharmaceutical Market1.2 Bioscience Industry Facts That Impact Bio-computing1.3 Bio-computing Opportunity Roadmap1.4 Current Bio-Computing Market Participants1.5 Bioscience Computing Infrastructure Requirements1.6 Bio-Computing Technologies1.6.1 Computer Infrastructure1.6.2 Storage Network Infrastructure1.6.3 Application Software1.6.4 Other1.7 The Pharma Business 2. Drivers of Bio-Computing2.1 Drivers of Bio-computing + Pharmaceuticals 2.1.1 Pharma Drug Discovery R&D2.1.2 Rapid Pace of Scientific Developments2.1.3 Current Computing Power is Affordable for Pharma R&D2.1.4 Post Human Genome Project Era Databases2.1.5 Computational Requirements for Structural and Functional Proteomics R&D2.1.6 Food Production Development2.2 Commercial Applications 2.2.1 Genomic Databases2.2.2 Proteomic Databases2.2.3 Applications3. Case Studies in Bio-computing for Pharma R&D3.1 Hardware Solutions 3.1.1 Agencourt Biosciences and Auspex Storage Solution3.1.2 Bristol Myers Squibb, SGI and Incyte Genomics3.1.3 Incyte Genomics and Red Hat Linux Compute Farm3.1.4 National Cancer Institute and Genomics Pattern Matching With Supercomputer3.2 Services Solutions 3.2.1 Celera Genomics, Blackstone Computing and Compaq Build Massive Compute Solution3.2.2 Hospital for Sick Children Genomic Database and IBM Services3.3 Software Solutions 3.3.1 Aventis and In Silico Drug Discovery3.3.2 Biogen, Inc. and Spotfire DecisionSite3.3.3 Eli Lilly and Clinical Trial e-Business Patient Recruitment3.3.4 Proctor and Gamble Pharmaceuticals and Phase Forward, Inc. Clinical Trial Management4. The Bio-Computing IT Market and Future Outlook4.1 The Bio-Computing IT Market and Industry Segments 4.1.1 IT Services4.1.2 Servers4.1.3 Storage4.1.4 Software4.1.5 BioContent4.2 Bio-Computing IT Market Size by Segment, 2001~20054.3 Total Size of the Bio-Computing IT Market4.4 Forecast for Bio-computing R&D Market by Market Segments4.4.1 The Bio-computing IT 'Services' Market Segment4.4.2 Forecast for the Bio-Computing 'Server' Market Segment4.4.3 Forecast for the Bio-computing IT 'Storage' Market Segment4.4.4 Forecast for the Bio-computing IT 'Software' Market Segment4.4.5 Forecast for the Bio-computing IT BioContent Market Segment4.4.6 Comparison of the Market Segment Forecasts5. Future Directions in Bio-Computing5.1 Overview of Past Trends 5.1.1 Recent Developments in Genomics That Impact on Bio-computing5.1.2 Rapid Changes in Computer Systems5.2 Indicators of Future Trends for Bio-Computing 5.2.1 Services5.2.2 Software5.2.2.1 Operating Systems.5.2.2.2 Applications.5.2.2.3 Tools for Computational Flexibility5.2.3 Biocontent5.2.4 Servers5.2.5 Storage6. Activities of Emerging Bio-Computing R&D IT Infrastructure Firms6.1 BioContent Providers 6.1.1 Celera Genomics Corporation6.1.2 Human Genome Sciences, Inc.6.1.3 Incyte Genomics, Inc. 6.1.4 NuTec Sciences, Inc., Life Science Div.6.2 BioSoftware Application Providers6.2.1 Accelrys, Inc. (subsidiary of Pharmacopeia Inc.)6.2.2 Cellomics, Inc.6.2.3 InforMax, Inc.6.2.4 Spotfire, Inc.6.3 Hardware Systems Providers 6.3.1 Compaq Computer Corporation6.3.2 IBM Corporation6.3.3 Paracel, Inc.6.4 Services Providers 6.4.1 Blackstone Computing6.4.2 Entigen Corporation6.4.3 Linux NetworX, Inc.6.5 Systems Software Providers6.5.1 Red Hat Linux, Inc.6.5.2 Turbolinux, Inc.7. Lessons Learned and Emerging Opportunities7.1 Challenges of Drug Discovery R&D and Bio-computing 7.1.1 Science Bottlenecks Need to be Converted Computational Problems7.1.2 Genomics BioContent to Become a Commodity7.2 Review of the Next Hot Development Areas in Bio-Computing 7.2.1 More 'Big Iron' in Bio-Computing7.2.2 Bio-Computing in Clinical Trials7.2.3 Personalized Medicine to Become a Theme7.3 Bio-Computing Opportunities 7.3.1 Role in Drug Discovery7.3.2 High Storage Growth Ahead7.3.3 Fast Growth Rates Expected for Consulting and e-Services7.3.4 Software Opportunities7.4 Summary 7.4.1 Vendors Need to Become Partners with Pharmas7.4.2 Bio-computing to Increase Chances of Pharma Success8. Appendix 1 - Selection of Bio-computing Vendors 9. Appendix 2 - Bioscience Glossary LIST OF TABLES Table 1. Magnitude of Bio-computational RequirementsTable 2. Computing Power Needed for Genomic & Protein R&DTable 3. Forecast for the Total Bio-computing IT Market, 2001-2005Table 4. Forecast for the Bio-computing IT 'Services' Market Segment, 2001-2005Table 5. Forecast for the Bio-computing IT 'Server' Market Segment, 2001-2005Table 6. Forecast for the Bio-computing IT 'Storage' Market Segment, 2001-2005Table 7. Forecast for the Bio-computing IT 'Software' Market Segment, 2001-2005Table 8. Forecast for the Bio-computing IT BioContent Market Segment, 2001-2005Table 9. Comparison of Forecasts for the Total Bio-computing IT Market, 2001-2005Table 10. Selected Services VendorsTable 11. Selected Software VendorsTable 12. Selected BioContent VendorsTable 13. Selected Server VendorsTable 14. Selected Storage VendorsLIST OF FIGURES Figure 1. Drug R&D SummaryFigure 2. Bio-Computing Opportunity MapFigure 3. Bio-computing Vendor MarketFigure 4. Agencourt Biosciences and Network Storage SolutionFigure 5. Bristol-Myers Squibb and a Two Supercomputer SolutionFigure 6. Incyte Genomics and Linux Cluster SolutionFigure 7. Computer Model using PhysioLab TechnologyFigure 8. The SpotFire DecisionSite User InterfaceFigure 9. InForm Web-based Clinical Trial Management ScreenFigure 10. Forecast for the Total Bio-computing IT Market, 2001-2005Figure 11. Forecast for the Bio-computing IT 'Services' Market Segment, 2001-2005Figure 12. Forecast for the Bio-computing IT 'Server' Market Segment, 2001-2005Figure 13. Forecast for the Bio-computing IT 'Storage' Market Segment, 2001-2005Figure 14. Forecast for the Bio-computing IT 'Software' Market Segment, 2001-2005Figure 15. Forecast for the Bio-computing IT 'BioContent' Market Segment, 2001-2005Figure 16. Comparison of Forecasts for the Total Bio-computing IT Market, 2001-2005Figure 17. Comparison of Segment Market Shares for the Bio-computing IT Market, 2001 and 2005Figure 18. Next Generation Scyld Beowulf cluster ComputerFigure 19. Big Pharma Drug Development Timeline.Figure 20. Drug Discovery Collaboration Map
Customers who bought this item also bought
Worldwide Cloud Computing Market Opportunities and Segment Forecasts 2009 to 2015
U.S. Next Generation Bio-Tools for Accelerating Bio-Pharmaceutical Drug Discovery R&D: Technologies, Opportunities and Markets
World Bio-Informatics Market (2005-2010)
Worldwide Cell Based Screening & Analysis Market for Bio-Pharma Drug Discovery
Global Cloud Computing Services Market 2008-2011
Worldwide Cell Based Screening & Analysis Market for Bio-Pharma Drug Discovery
Bio Nanotechnology
Worldwide Cloud Computing Market Shares, Strategies, and Forecasts, 2009-2015
Cloud Computing: The Wave of the Future
Bio/Pharma R&D Statistical Sourcebook 2008/2009
Mobile Broadband Computing: Device Market Forecasts & Business Model Scenarios
Bio Imaging
|
|
|
|
